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and Oscar Palomares1*Abstract
Background: The 11S globulin Sin a 2 is a marker to predict severity of symptoms in mustard allergic patients. The
potential implication of Sin a 2 in cross-reactivity with tree nuts and peanut has not been investigated so far. In this
work, we studied at the IgG and IgE level the involvement of the 11S globulin Sin a 2 in cross-reactivity among
mustard, tree nuts and peanut.
Methods: Eleven well-characterized mustard-allergic patients sensitized to Sin a 2 were included in the study. A
specific anti-Sin a 2 serum was obtained in rabbit. Skin prick tests (SPT), enzyme-linked immunosorbent assay
(ELISA), immunoblotting and IgG or IgE-inhibition immunoblotting experiments using purified Sin a 2, Sin a 1, Sin a
3, mustard, almond, hazelnut, pistachio, walnut or peanut extracts were performed.
Results: The rabbit anti-Sin a 2 serum showed high affinity and specificity to Sin a 2, which allowed us to
demonstrate that Sin a 2 shares IgG epitopes with allergenic 11S globulins from tree nuts (almond, hazelnut,
pistachio and walnut) but not from peanut. All the patients included in the study had positive skin prick test to tree
nuts and/or peanut and we subdivided them into two different groups according to their clinical symptoms after
ingestion of such allergenic sources. We showed that 11S globulins contain conserved IgE epitopes involved in
cross-reactivity among mustard, tree nuts and peanut as well as species-specific IgE epitopes.
Conclusions: The allergenic 11S globulin Sin a 2 from mustard is involved in cross-reactivity at the IgE level with
tree nuts and peanut. Although the clinical relevance of the cross-reactive IgE epitopes present in 11S globulins
needs to be investigated in further detail, our results contribute to improve the diagnosis and management of
mustard allergic patients sensitized to Sin a 2.
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lgG/IgE epitopesBackground
IgE-mediated food allergy is an important worldwide
health problem of increasing prevalence affecting up to
2-10% of the population [1,2]. More than 170 foods have
been reported to induce allergic responses being pea-
nuts, tree nuts, eggs, milk, fish, shellfish, wheat and soy
responsible for the vast majority of reactions. Mustard is
one of the most frequent spices causing IgE-mediated* Correspondence: oscar.palomares@quim.ucm.es
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reproduction in any medium, provided the orfood allergy, and together with celery, sesame, lupine
and shellfish is considered among the most significant
allergenic sources in European countries [3]. The inges-
tion of mustard seed flour or manufactured foods con-
taining this spice has been frequently associated with the
development of severe symptoms such as generalized ur-
ticaria, angioedema or anaphylaxis in hypersensitive
patients [4-7]. Mustard is worldwide consumed in
home-made meals and added as a hidden condiment in
many sauces, salad dressings or manufactured and pro-
cessed products, which makes difficult to avoid the in-
gestion of this spice and increases the risk of sufferingLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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mustard content must be declared according to the
European Union directive for food labelling [9]. Yellow
mustard (Sinapis alba L.) is commonly used in Europe
whereas oriental mustard (Brassica juncea) is the spice
used in United States and Asia.
Four allergens from yellow mustard seeds have been
identified, purified and characterized so far: i) 2S albu-
min Sin a 1 (14 kDa) [10,11]; ii) 11S globulin Sin a 2
(51 kDa) [12,13]; iii) LTP Sin a 3 (12 kDa) [14]; and iv)
profilin Sin a 4 (13–14 kDa) [14]. Sin a 1 and Sin a 3 but
not Sin a 4 might act as genuine food allergens able to
reach the gut immune system due to their high struc-
tural and immunological stability [15]. The capacity of
Sin a 2 to act as primary sensitizer at the intestinal mu-
cosa has not been investigated so far. We also demon-
strated that Sin a 1 is a diagnostic marker for
sensitization to mustard, Sin a 2 is a marker to predict
severity of symptoms, and Sin a 3 and Sin a 4 are aller-
gens associated with sensitization to other plant-derived
foods from the Rosaceae family and pollens [16]. It has
been reported that more than 50% of patients allergic to
mustard present hypersensitivity to other different vege-
table foods, mainly nuts and legumes, but whether this
is due to cross reactivity and the allergens involved in
such processes is an aspect that needs further investiga-
tions [16-18]. At this regard, 11S globulins might repre-
sent good candidates. Allergenic members of this
protein family have been characterized from almond
(Pru du 6) [19], hazelnut (Cor a 9) [20,21], peanut
(Ara h 3) [22], walnut (Jug r 4) [23], pistachio (Pis v 2)
[24], soybean (glycinins G1-G2) [25], Brazil nut (Ber e 2)
[26], cashew nut (Ana o 2) [27], sesame seeds (Ses i 6)
[28] or pecan (Car i 4) [29]. Some studies have previ-
ously shown that 11S globulins are involved in cross-
reactivity between coconut and walnut [30], among
buckwheat, poppy and hazelnut [31] or between peanut
and other different seeds spices [32]. In addition, two
more detailed studies at the molecular level based on
the three-dimensional (3D) structure of the allergens
and identification of IgE-binding sites suggested that Jug
r 4 shows cross-reactivity with Car i 4 [29] or with Cor a
9 and other 11S globulins [33,34]. Despite these reported
data, there is still little evidence of IgE-cross reactivity
involving 11S globulins, a family of proteins with an
overall sequence identity under 40%.
In the present study, we sought to investigate the po-
tential implication of the 11S globulin Sin a 2 in cross-
reactivity involving mustard, tree nuts and peanut. Our
results show that the allergenic 11S globulin Sin a 2
shares IgG epitopes with homologous counterparts from
almond, hazelnut, pistachio and walnut but not from
peanut and that Sin a 2 is involved in IgE cross-
reactivity with tree nuts and peanut.Methods
Patients allergic to mustard
The patients included in this study were a subgroup of
well-characterized patients allergic to mustard [16] who
presented specific IgE antibodies against purified 11S
globulin Sin a 2 as determined by both enzyme-linked
immunosorbent assay (ELISA) and skin prick test (SPT).
Allergy to mustard was diagnosed as previously
described [35]. During the patient consultation a ques-
tionnaire gathering clinical information was filled out by
an allergist. Clinical features of the patients are shown in
Table 1. Although not all of the patients were allergic to
tree nuts and/or peanut, all of them had positive SPT to
at least one of these allergenic sources. We pooled
patient’s sera into two different groups: i) Group 1,
patients without clinical symptoms to tree nuts and/or
peanut; ii) Group 2, patients with clinical symptoms to
some of these allergenic sources (Table 1, Table 2).
Serum samples from all the patients were collected and
storage at −20°C until used. Sera from a non-atopic sub-
ject and from an olive pollen-allergic patient were used
as controls. The study was approved by the Fundación
Jiménez Díaz Ethic Committee (Madrid), and written
informed consent was obtained from all subjects.Yellow mustard seeds extract, purified Sin a 2 and rabbit
anti-Sin a 2 serum
Yellow mustard seeds, almond, hazelnut, pistachio, wal-
nut and roasted peanut protein extracts were obtained
as previously described for yellow mustard seeds [12].
The allergenic 11S globulin Sin a 2 was purified from
yellow mustard seeds extract as described [12].
The specific anti-Sin a 2 serum was prepared by im-
munizing a New Zealand white rabbit with purified Sin
a 2 by weekly injection of the protein in complete
Freund’s adjuvant. After 21 days of treatment the serum
was obtained by centrifugation of the blood.Skin-prick tests
SPT were performed in all patients according to stand-
ard procedures [36]. The panel of commercial food
extracts included peach, chestnut, soy, sunflower seed,
almond, hazelnut, peanut, walnut, pine nut, pistachio,
chickpea, lentil and bean. SPT with kiwi and apple were
performed by the prick-prick method as described [37].
SPT with home-made mustard (Sinapis alba L.) extract
(50 μg/ml) and with purified natural Sin a 2 (10 μg/ml)
were performed. Histamine dihydrochloride (10 mg/ml)
and physiologic saline solutions were used as the
positive and negative controls, respectively. A wheal
area <7 mm2 was considered as negative. We included
almond as a nut (instead of a Rosaceae fruit), and con-
sidered peanut separately.










Mustard Sin a 2 Almond Hazelnut Pistachio Walnut Peanut
GROUP 1 1 F/51 OAS, U, AE, D 221 69 no 16 19 Neg 9 Neg -
2 M/50 OAS, AE, D 97 52 no Neg Neg Neg 15 Neg -
3 M/29 OAS, U, RC, D 87 37 r, l, m Neg 30 22 36 29 -
4 M/36 OAS, U 137 139 r, m 20 10 20 18 17 -
5 F/54 OAS, U, TT, A, RC, D 101 35 r, k Neg Neg Neg 18 39 -
GROUP 2 6 F/30 OAS,CU,TT, D 119 46 k, n 15 Neg Neg 9 7 OAS
7 M/30 OAS,U, AE, TT, A, RC, D 103 50 r, n, p Neg Neg 14 Neg Neg OAS
8 M/30 OAS, U, AE, TT, A, RC 171 83 n 21 14 11 8 17 OAS, RC, A
9 M/30 OAS, AE, A, RC 169 22 r, k, n, p, m 21 82 35 124 38 OAS, AE, TT
10 F/31 OAS, AE, CU, TT, A 55 25 r, k, n, p, m 23 57 40 59 64 OAS, AE, TT, RC
11 M/6 OAS, TT (local) 73 8 k, n Neg 56 Neg 54 Neg AE, U
M/F, male/female; A, asthma; AE, angioedema; CU, contact urticaria; D, digestive symptoms; OAS, oral allergy syndrome; RC, rhinoconjuctivitis; U, urticaria; TT, throat
tightness; k, kiwi; l, legumes; m, melon; n, nuts (including almond); p, peanut; r, rosaceae family (excluding almond); Neg, negative (< 0.100 for ELISA and wheal
area < 7 mm2 for SPT).
* Skin prick test: wheal area in mm2.
Group 1: Tolerant to tree nuts and peanut.
Group 2: Symptoms with tree nuts and/or peanut.
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SDS-PAGE was performed in 15% polyacrylamide gels.
Proteins (0.5 μg/lane of purified proteins or 50 μg/lane
of protein extracts) were visualized by Coomassie Blue
or alternatively transferred to nitrocellulose membranes
(Amersham, Buckinghamshire, United Kingdom). The
protein concentration was determined using the method
of bicinchoninic acid (Pierce Chemical Co, Rockford, Ill,
USA).
Immunodetection of proteins in membranes was
achieved as described [14] by using different pool of sera
from patients allergic to mustard, (diluted 1/5), or rabbitTable 2 Specific IgE to mustard extract and purified
mustard allergens by ELISA
ELISA‡ OD492
Patient Nº Mustard Sin a 1 Sin a 2 Sin a 3 Sin a 4
GROUP 1 1 3.366 3.186 0.980 Neg Neg
2 1.041 0.590 0.787 Neg Neg
3 2.809 2.648 0.466 1.580 0.857
4 3.500 3.500 2.138 Neg Neg
5 0.847 0.553 0.529 Neg Neg
GROUP 2 6 3.477 3.532 2.138 Neg Neg
7 1.327 1.153 0.119 Neg Neg
8 0.934 0.920 0.166 Neg Neg
9 0.856 0.643 0.162 0.117 Neg
10 0.441 0.398 0.111 1.965 0.979
11 1.508 0.738 0.216 Neg Neg
‡ Specific IgE determined in ELISA as OD at 492 nm. Neg, negative (< 0.100).
Group 1: Tolerant to tree nuts and peanut.
Group 2: Symptoms with tree nuts and/or peanut.specific anti-Sin a 2 serum (diluted 1/100000). The bind-
ing of human IgE was detected by mouse anti-human
IgE antibodies, provided by ALK-Abelló (Madrid, Spain),
diluted 1/5000, followed by horseradish peroxidase-
labelled goat anti-mouse IgG (diluted 1/5000; Pierce).
Reaction to anti-Sin a 2 serum was detected by horse-
radish peroxidase-labelled goat anti-rabbit IgG (diluted
1/3000; BioRad, Richmond, CA). The signal was
developed by using the ECL-Western blotting reagent
(Amersham). For the IgG and IgE-inhibition experi-
ments in immunoblotting, the pools of sera (diluted 1/5)
or the rabbit anti-Sin a 2 serum (diluted 1/100000)
were preadsorbed with 1 mg/ml of yellow mustard seeds,
almond, hazelnut, walnut, pistachio or peanut extracts
or with 20 μg/ml of purified Sin a 2 for 2h prior to
membrane incubation as described [38]. Bovine serum
albumin (BSA) was used as negative controls of inhib-
ition. Volummograms of the reactive bands were ana-
lysed by scanning densitometry using the computer
program Multigauge V3.0.ELISA experiments
IgG quantitation was performed by ELISA in microtiter
plates (Costar, Corning, NY, USA) coated with 100 μl/
well of purified Sin a 2 (2 μg/ml) or yellow mustard
seeds extract (20 μg/ml) [14]. Plates were incubated with
increasing dilutions of the rabbit anti-Sin a 2 serum for
titration. Then, the plates were incubated with horserad-
ish peroxidase-labelled goat anti-mouse IgG as describe
above and peroxidase reaction was developed using fresh
enzyme substrate and measuring optical density (OD) at
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2 determinations after blank subtraction.
For IgG-inhibitions ELISA, after being coated with
100 μl of Sin a 2 (2 μg/ml) or yellow mustard seeds ex-
tract (20 μg/ml), the plates were incubated with the
rabbit anti-Sin a 2 serum (diluted 1/100000) previously
preadsorbed with increasing amounts of Sin a 2 and
mustard extracts as inhibitors for 2 h [38]. Then, the
plates were incubated with horseradish peroxidase-
labelled goat anti-mouse IgG and peroxidase reaction
developed as described above. The percentage of in-
hibition was determined according to the formula: % In-
hibition = (1- (OD492nm with inhibitor/OD492nm without
inhibitor)) x 100. All the determinations were carried
out as duplicates.
Sequence alignment and three-dimensional modelling
Multiple sequence alignments of Sin a 2, Pru du 6, Cor a
9, Pis v 2, Jug r 4 and Ara h 3 (accession numbers
Q2TLW0, E3SH28, Q8W1C2, B7P073, Q2TPW5 and
O82580, respectively) were performed with the Clustal
Omega program [39]. Amino acid sequences of all 11S
globulins are shown without signal peptide. Location of
the signal peptide cleavage sites were predicted using
SignalP 4.0 Server [40]. The 3D structure of Sin a 2 was
modelled by using the services of the Swiss-Model Pro-
tein Modelling Server [41] and the structure of the soy-
bean legumin Gly m 6 (PDB code 1od5A) [42] as
template. The 3D structure of Ara h 3 correspond to
PDB: 3c3v. Graphical processing of the three-
dimensional structures was accomplished with PDB
viewer PyMOL program.
Results and discussion
Clinical features of mustard-allergic patients sensitized to
Sin a 2 suggest that 11S globulins might be involved in
cross-reactivity with tree nuts and/or peanut
By linking the clinical features of 34 well-characterized
patients allergic to mustard with component-resolved
approaches we previously showed that 2S albumin Sin a
1 is a marker of genuine sensitization to mustard, 11S
globulin Sin a 2 is associated to severe symptoms after
mustard ingestion and LTP Sin a 3 and profilin Sin a 4,
two well-known panallergens, are associated with
sensitization to other plant-derived foods from the Rosa-
ceae family and pollens [16]. Although more than 50%
of mustard allergic patients are also sensitized to tree
nuts and/or peanut, significant clinical associations be-
tween sensitization to Sin a 2 and being allergic to other
tree nuts or peanut were not found within our cohort of
mustard allergic patients [16]. However, considering that
recent studies suggested that 11S globulins are impli-
cated in cross-reactivity among taxonomically unrelated
tree nuts and peanut [30-33] and that different membersof this protein family have been reported as relevant
allergens [19-24], we investigated at the IgG and IgE
level whether the 11S globulin Sin a 2 might be impli-
cated in cross-reactivity among mustard, tree nuts and
peanut within mustard allergic patients specifically sensi-
tized to Sin a 2. We included in the study the 11 patients
allergic to mustard with the general clinical characteris-
tics summarized in Table 1. All patients presented aller-
gic reactions within the first 30 minutes after mustard
consumption and the inclusion criteria was based on
positive specific IgE to yellow mustard seed extract and
Sin a 2 as determined by SPT and ELISA (Tables 1 and
2). In line with our previous data, 10 of the 11 patients
sensitized to Sin a 2 developed immediate systemic reac-
tions after the ingestion of mustard and 7 attended the
emergency room, where epinephrine was administrated
[16]. All the patients included in the study had also posi-
tive SPT to tree nuts (almond or hazelnut or pistachio
or walnut) or peanut and 6 of them (# 6, 7, 8, 9, 10 and
11) suffered from symptoms after ingestion of tree nuts
(3 of them also with peanut, # 2, 4 and 5). Interestingly,
only 3 patients showed positive specific IgE to the previ-
ously known cross-reactive mustard allergens Sin a 3
and 2 to Sin a 4 (Table 2), suggesting a potential role of
Sin a 2, at least in the observed positive SPT to tree nuts
and/or peanut. To further analyse the implication of Sin
a 2 in cross-reactivity at the IgG and IgE level and to de-
termine potential clinical relevance within the mustard
allergic patients sensitized to Sin a 2, we obtained a
rabbit anti-Sin a 2 serum and pooled patients’ sera into
two different groups: i) Group 1, patients with positive
SPT to tree nuts and/or peanut extracts without clinical
symptoms to these allergenic sources; ii) Group 2,
patients with positive SPT to tree nuts and/or peanut
extracts with clinical symptoms to some of these aller-
genic sources (Table 1).
IgG epitopes of the 11S globulin Sin a 2 are present in
almond, hazelnut, pistachio and walnut but not in peanut
extracts
Compelling experimental evidence demonstrated that
the use of well-defined purified allergens is very useful
to improve diagnosis and treatment of allergic diseases
[43,44]. The availability of purified allergens allows the
obtaining of specific polyclonal antibodies in mice or
rabbit, which are key tools in the identification of poten-
tial cross-reactive homologous allergens in taxonomic-
ally related and non-related allergenic sources [14,45].
We employed purified Sin a 2 to raise a rabbit anti-Sin a
2 serum as described in the methods section. The spe-
cific anti-Sin a 2 serum was titrated against purified Sin
a 2 and yellow mustard seeds extract by ELISA and im-
munoblotting (Figure 1A and B). As shown in
Figure 1A, the rabbit anti-Sin a 2 serum displayed equal
Figure 1 Characterization and validation of the rabbit anti-Sin a 2 serum. A) ELISA titration of Sin a 2 (0.2 μg/well) and mustard extract
(20 μg/well) using the rabbit specific anti-Sin a 2 serum. B) Immunoblotting of mustard extract (50 μg/lane) or purified Sin a 2 (0.5 μg/lane)
using different dilutions of the anti-Sin a 2 serum. Molecular mass markers are displayed in the left margin. C) ELISA-inhibition experiments of
the IgG-binding to Sin a 2 or mustard extract-coated wells with increasing concentrations of Sin a 2 or mustard as inhibitors.
D) Immunoblotting-inhibition experiments of the IgG-binding to nitrocellulose blotted mustard extract (50 μg/lane) or Sin a 2 (0.5 μg/lane)
using as inhibitors BSA (20 μg/mL), Sin a 2 (20 μg/ml) or mustard (1 mg/ml). Molecular mass markers are displayed in the left margin.
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tard extract, demonstrating that purified Sin a 2 con-
served the IgG epitopes and that the employed rabbit
anti-Sin a 2 serum is specific to this allergen. The anti-
Sin a 2 serum also recognized the protein band at
around 51 kDa, corresponding to Sin a 2, in the mustard
extract and the purified allergen in a dose-dependent
manner in immunoblotting (Figure 1B). When the rabbit
anti-Sin a 2 serum was employed at the highest con-
centration (dilution 1/50000), protein bands at around
30–32 kDa were slightly detected in both cases. These
protein bands, which are also recognized by sera from
mustard allergic patients, were previously identified as
proteolytic fragments of Sin a 2 in mustard extract [13].
To further verify the specificity of the anti-Sin a 2 serum
we performed IgG-inhibition experiments in ELISA and
immunoblotting (Figure 1C and D). As shown in these
figures, both purified Sin a 2 and mustard extract were
able to block IgG binding to whole mustard extract or to
Sin a 2-coated wells in a similar manner (Figure 1C).
Complete inhibition of the binding of the anti-Sin a 2
serum to mustard extract or to purified Sin a 2 was
reached when purified Sin a 2 or whole mustard extractwere employed as inhibitors (Figure 1D). Collectively, all
these data showed that the raised rabbit anti-Sin a 2
serum displays high affinity and specificity for the aller-
genic 11S globulin Sin a 2. Next, we tested the presence
of IgG epitopes common to Sin a 2 in tree nut (almond,
hazelnut, pistachio and walnut) and peanut extracts
(Figure 2). These tree nuts and peanut extracts were
selected because they were the most relevant allergenic
sources to which the patients included in the study were
allergic to or had positive SPT (Table 1). In Figure 2A,
the Coomassie Blue staining after SDS-PAGE is dis-
played to visualize the protein content of the different
extracts. The anti-Sin a 2 serum (lanes I) but not the
pre-immune one (lanes P) reacted with protein bands at
around 48–52 kDa in all the tested tree nut extracts. No
reaction was detected when peanut extract was assayed.
These results demonstrated that the previously described
allergenic 11S globulins from almond (Pru du 6),[19]
hazelnut (Cor a 9) [20], pistachio (Pis v 2) [24] and
walnut (Jug r 4) [23] but not from peanut (Ara h 3) [22]
share common IgG epitopes with Sin a 2. As shown in
Figure 3, despite showing quite low percentages of iden-
tity (ranging between 28 and 39%) and similarity
Figure 2 Identification of IgG cross-reactive 11S globulins
homologous to Sin a 2 in tree nut extracts. A) SDS-PAGE and
Coomassie Blue staining (CBS) of 40 μg/lane of mustard, almond,
hazelnut, walnut, pistachio and peanut protein extracts. B) Reactivity
of the anti-Sin a 2 serum diluted 1/50000 (lanes I) to mustard,
almond, hazelnut, walnut, pistachio and peanut protein extracts
(50 μg/lane). A pre-immune rabbit serum (lanes P) was used at the
same dilution as negative control. Molecular mass markers are
displayed in the left margin.
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present regions with conserved amino acid sequences
such as for example those encompassing Gly89-Asp96,
His155-Asp165 or Phe420-Ser436 (underlined in Figure 3).
Ara h 3 is the 11S globulin showing the lowest identity
(28%) and similarity (46%) with Sin a 2 and significant
differences in the amino acid sequences of the above
mentioned regions are also observed (Figure 3). There-
fore, the presence of IgG binding sites at these regions,
which do not completely overlap with the previously
identified IgE hot spots (HS), might well justify the lack
of reactivity of the anti-Sin a 2 serum against Ara h 3.
To complement these data, we performed IgG-inhibition
experiments in immunoblotting using BSA, purified Sin
a 2 or mustard as controls, and almond, hazelnut, pista-
chio or walnut as potential inhibitors of the IgG binding
to purified Sin a 2 (Figure 4A). The reactivity to Sin a 2
of the anti-Sin a 2 serum preadsorbed with purified Sin
a 2 or mustard extract was nearly abolished (95 and 99%
of inhibition respectively, quantified by scanning densi-
tometry). When tree nut extracts were employed as inhi-
bitors, an important reduction of the IgG-binding to
Sin a 2 was also reached in all the cases. Almond and
walnut were the extracts showing the highest inhibitory
capacity (77% and 60% of inhibition, respectively) fol-
lowed by hazelnut (53%) and pistachio (43%) as deter-
mined by scanning densitometry. Sin a 2 displays a
region enriched in Gln and Gly (positions Gly118-Arg152,
Figure 3), which is contained exclusively in Pru du 6. If
this segment bears IgG binding sites, it might justify the
highest percentage of inhibition reached by almond ex-
tract. As expected considering that the specific rabbit
serum was raised against purified Sin a 2, the IgG bind-
ing to almond, hazelnut, pistachio and walnut wascompletely abolished when purified Sin a 2, mustard or
the corresponding tree nut extract were used as inhibi-
tors (Figure 4B). Collectively, all these results firmly
demonstrated that Sin a 2 shows cross-reactivity with
the allergenic 11S globulins from almond, hazelnut, pis-
tachio and walnut at the IgG level, indicating that des-
pite their low percentage of sequence identity they share
IgG epitopes likely located in the most conserved
regions of the protein family.
IgE cross-reactivity among allergenic 11S globulins from
mustard, tree nuts and peanut
To gain insight into the potential role of Sin a 2 in
cross-reactivity involving mustard, tree nuts and peanut
at the IgE level, we performed IgE-inhibition experi-
ments in immunoblotting using purified Sin a 2 and al-
lergenic protein extracts from mustard, different tree
nuts (almond, hazelnut, pistachio and walnut) and pea-
nut. We pooled the patients’ sera into two different
groups. In the group 1 we included the 5 patients with-
out clinical symptoms to tree nuts and/or peanut at the
moment of the study and in the group 2 the 6 patients
that were allergic to tree nuts (3 of them also to peanut)
(Table 1). As shown in Figure 5A, the reactivity to puri-
fied Sin a 2 of the pool of sera from group 1 preadsorbed
with almond, hazelnut, walnut, pistachio or peanut was
inhibited at different level depending on the employed
extract. By scanning densitometry we quantified that al-
mond (63% of inhibition) was the most potent inhibitor
followed by walnut, pistachio, peanut and hazelnut (49%,
34%, 32%, and 15%, respectively). Interestingly, the pool
of sera from group 1 recognized allergenic 11S globulins
homologous to Sin a 2 in almond, hazelnut, pistachio,
walnut and peanut. The IgE-binding to these proteins
was nearly totally abolished when the pool of sera was
preadsorbed with purified Sin a 2 except for hazelnut
and peanut (Figure 5B), which might be due to co-
sensitization to species-specific epitopes from 11S globu-
lins contained in these allergenic extracts, the existence
of different allergenic isoforms or the presence of add-
itional allergens with the same molecular weight in
hazelnut and peanut. These results show that for these
patients Sin a 2 is the sensitizing allergen that shares
common IgE epitopes with allergenic 11S globulins from
the assayed extracts, which could explain why these
patients despite of not suffering from clinical symptoms
to tree nuts or peanut show in vivo positive SPT to such
allergenic sources. To further investigate the potential
clinical relevance of 11S globulin Sin a 2 in cross-
reactivity, we performed the same type of experiments
using the pool of sera from the mustard allergic patients
sensitized to Sin a 2 with clinical symptoms to tree nuts
and/or peanut (group 2). As shown in Figure 5C, the
IgE-binding to purified Sin a 2 was significantly inhibited
Figure 3 Alignment of sequences of allergenic 11S globulins. Yellow mustard seeds (Sin a 2), almond (Pru du 6), hazelnut (Cor a 9), pistachio
(Pis v 2), walnut (Jug r 4) and peanut (Ara h 3) (UniProt accession numbers Q2TLW0, E3SH28, Q8W1C2, B7P073, Q2TPW5 and O82580,
respectively). (−) for gaps. Residues conserved in all proteins are in black, and those conserved in at least 4 sequences are in grey. Underlined
regions correspond to partially conserved amino acid sequences in the compared 11S globulins with the exception of Ara h 3. The sequences
contained in the white square represent the additional segment of sequence enriched in Gly and Gln only presented in Sin a 2 and Pru du 6.
Colored squares contain the five sequence regions previously described as IgE hot spots in 11S globulins. %I and %S, percentages of identity and
similarity, respectively. Amino acid numbering for each sequence is given in the right margin.
Figure 4 IgG-inhibition experiments in immunoblotting. Inhibition experiments of the IgG-binding of the rabbit anti-Sin a 2 serum
(1/100000 diluted) to A) Sin a 2 and B) almond, hazelnut, pistachio and walnut protein extracts (50 μg of total protein per lane). BSA (20 μg/ml),
Sin a 2 (20 μg/ml), mustard, hazelnut, pistachio or walnut protein extracts (1 mg/ml) were used as inhibitors. Molecular mass markers are
displayed in the left margin.
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Figure 5 IgE-inhibition experiments in immunobloting. A) Inhibition of the IgE-binding to purified Sin a 2 of the pool of sera (1/5 diluted)
from the group 1 of patients using as inhibitors BSA (20 μg/ml), Sin a 2 (20 μg/ml), almond, hazelnut, pistachio, walnut and peanut protein
extracts (1 mg/ml). B) Inhibition of IgE-binding to almond, hazelnut, pistachio, walnut and peanut extracts (50 μg of total protein per lane) of the
pool of sera from group 1 (1/5 diluted) using as inhibitors BSA (control) or purified Sin a 2 (20 μg/ml). C, D and E) The same type of
IgE-inhibition experiments using the pool of sera from the group 2 of patients and the indicated inhibitors. Molecular mass markers
are displayed in the left margin.
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(83%, 62%, 60%, 67%, 69% and 67% of inhibition, re-
spectively, as determined by scanning densitometry).
This result firmly confirms that Sin a 2 share common
IgE epitopes with allergenic 11S globulins from tree nuts
and peanuts. This pool of sera (group 2) also recognized
IgE-reactive protein bands at around 48–52 kDa that
were not inhibited by Sin a 2 except in the case ofalmond (20% of inhibition by scanning densitometry)
(Figure 5D). These results together with the fact that the
inhibition of the IgE-binding to purified Sin a 2 by tree
nut and peanut extracts was considerably higher for
group 2 than group 1 indicated that mustard allergic
patients sensitized to Sin a 2 and allergic to tree nuts
and/or peanut might well be also primarily co-sensitized
to 11S globulins from such allergenic sources. In
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ferent low-molecular weight IgE-reactive protein bands
(< 18 kDa) or epitopes from digested food that are not
present in patient group 1 (Figure 5D and E), which
could make the difference in the clinical symptoms asso-
ciated with tree nuts and/or peanut ingestion. Interest-
ingly, these IgE-reactive bands were not inhibited by 2S
albumin Sin a 1 nor LTP Sin a 3 (Figure 5E), indicating
that these families of allergenic proteins are not involved
in the observed cross-reactivity. Collectively, our data
suggest that Sin a 2 and the homologous allergenic 11S
globulins from the studied tree nuts and peanut might
contain both conserved cross-reactive and species-
specific IgE epitopes. At this regard, several studies have
previously shown the existence of five regions containing
IgE-binding HS on 11S globulins from tree nuts (al-
mond, hazelnut, cashew or walnut), peanut and soybean
[19,33]. Figures 3 and 6 show the amino acid sequence
alignment of such regions comparing Sin a 2, Pru du 6,
Cor a 9, Pis v 2, Jug r 4 and Ara h 3 as well as the loca-
tion of the five IgE-binding HS on the 3D modelling of
Sin a 2 and on the 3D structure of Ara h 3 . As shown
in Figure 6A, the previously proposed IgE-binding HS-2
and HS-4 are quite conserved among the compared al-
lergenic 11S globulins with percentages of identity with
respect to Sin a 2 ranging from 40% (Pis v 2 and Ara h 3
in HS-4) to 66% (Pru du 6 and Cor a 9 in HS-4). The
percentage of similarity with respect to Sin a 2 was even
significantly higher and ranged from 66% (Jug r 4 in HS-
2 and Pis v 2 in HS-4) to 86% (Pru du 6 in HS-2 and
Pru du 6 and Cor a 9 in HS-4). As visualized in the 3DFigure 6 Comparison of the IgE-binding hot spots among allergenic 1
Ara h 3. A) Table showing the percentage of identity (% I) and similarity (%
(Pru du 6), hazelnut (Cor a 9), pistachio (Pis v 2), walnut (Jug r 4) and peanu
hot spots on the molecular surface of the modelled 3D structure of Sin a 2
structures are colored in orange (hot spot 1), green (hot spot 2), yellow (homodelling of Sin a 2 and in the 3D structure of Ara h 3,
both HS-2 and HS-4 are located at solvent-exposed
areas of the monomer, thus representing ideal potential
IgE cross-reactive epitopes in allergenic 11S globulins.
When comparing HS-1, HS-3 and HS-5 lower percen-
tages of identity were observed, being the HS-5 the most
dissimilar. In addition, HS-1, HS-3 and HS-5 were not
completely solvent-exposed on the 3D modelling of Sin
a 2 or on the 3D structure of Ara h 3 suggesting that
they might well constitute potential species-specific
IgE epitopes. The identification of clinically relevant
IgE binding sites to which patients are sensitized
will contribute to improve diagnosis and accurate
endotyping, which might well subsequently lead to
develop more efficient and safer patient-tailored im-
munotherapy approaches [46-48]. Altogether, our study
indicates that mustard allergic patients sensitized to Sin
a 2 could present positive SPT to tree nuts and/or pea-
nut without clinical manifestations against these aller-
genic sources due to IgE cross-reactivity involving 11S
globulins. This finding is especially significant as it could
help to avoid wrong diagnosis due to IgE cross-reactivity
without clinical relevance. The fact that we also demon-
strated IgE cross-reactivity involving Sin a 2 in mustard
allergic patients sensitized to this allergen with clinical
symptoms to tree nuts and/or peanut suggests the possi-
bility that patients sensitized to Sin a 2 might eventually
develop clinical episodes against these allergenic sources.
Although the clinical relevance of the cross-reactive IgE-
binding sites of the 11S globulin Sin a 2 needs to be
studied in further detail, our results contribute to1S globulins and localization on the 3D structure of Sin a 2 and
S) of the five IgE hot spots described in 11S globulins from almond
t (Ara h 3) with respect to mustard (Sin a 2). B) Location of the IgE
and on the 3D structure of Ara h 3. Hot spot regions on the 3D
t spot 3), blue (hot spot 4) or red (hot spot 5).
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allergic to mustard sensitized to this allergen.
Conclusions
In this study we demonstrated at the molecular level
that the 11S globulin Sin a 2, which is associated with
severe reactions in mustard allergic patients, is involved
in cross-reactivity among mustard, tree nuts and peanut.
Sin a 2 shares IgG epitopes with allergenic 11S globulins
from tree nuts (almond, hazelnut, pistachio and walnut)
but not with peanut. At the IgE level, we showed that
11S globulins contain conserved IgE epitopes involved in
cross-reactivity among mustard, tree nuts and peanut as
well as specie-specific IgE epitopes. Due to the severity
of symptoms associated to Sin a 2, the definitive demon-
stration of the clinical relevance and the involvement of
the IgE cross-reactive epitopes of 11S globulins in trig-
gering symptoms is an important issue that will require
in depth clinical studies in future.
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